REDUCING THE PERCENTAGE OF PRESCRIBING ERROR FOR IRON DEXTRAN PRESCRIPTION IN OBSTETRICS AND GYNAECOLOGY (O&G) DEPARTMENT, HOSPITAL TENGKU AMPUAN RAHIMAH (HTAR), KLANG

Authors

  • Parimala Vijai Indrian Author
  • Low Shin Yee Author
  • P’ng Xiu Wen Author
  • Tan Huay Synn Author
  • Muna Atirah Ramli Author
  • Navamani Nedincheliyin Author

DOI:

https://doi.org/10.63719/qbulletin.v1i34.313

Keywords:

Iron dextran, Prescribing error, Dose calculation, Quality improvement study

Abstract

Prescribing errors can compromise patient safety and increase healthcare costs due to inappropriate indications. A verification study in the Obstetrics & Gynaecology (O&G) wards of Hospital Tengku Ampuan Rahimah (HTAR) in 2019 found that 46.7% of iron dextran prescriptions contained errors. The standard was 0% prescribing errors in iron dextran prescriptions. This quality improvement study involved all iron dextran prescriptions from the O&G wards. The verification study was conducted from August to December 2019, followed by cycle 1 (January - May 2020), cycle 2 (June - November 2020), and cycle 3 (January - April 2023). Data was collected via knowledge assessment questionnaires and iron dextran prescription analysis. Results showed that 48.6% was contributed by wrong dose, followed by 37.1% of incomplete prescriptions, 12.9% of wrong indication and 1.4% of wrong route. An iron dextran calculation worksheet with a QR code-linked user guide was introduced to quantify patients’ iron dextran requirement as part of cycle 1. A customary stamp was implemented at cycle 2 to standardise the iron dextran prescription. Cycle 3 was carried out with the introduction of the SteProCos Reminder Card to reinforce the process of prescribing, with the incorporation of a dosing table to recheck the calculated dose. Errors in iron dextran prescriptions decreased from 46.7% to 15.3% after the first cycle, further declining to 9.7% after the second cycle and 5.3% following the third. Prescribers’ knowledge regarding iron dextran increased from 62% to 94%. The implementation of these strategies resulted in hospital cost savings, with a total of MYR 1,956 saved annually on medication costs during the study period. The strategies were subsequently replicated by one of the cluster hospitals. The iron dextran calculation worksheet will be converted into a user-friendly electronic version, and internal audits along with continuous education sessions will be conducted at regular intervals.

Author Biographies

  • Parimala Vijai Indrian

    Pharmacy Department, Hospital Tengku Ampuan Rahimah, Selangor State Health Department, Ministry of Health Malaysia

  • Low Shin Yee

    Pharmacy Department, Hospital Tengku Ampuan Rahimah, Selangor State Health Department, Ministry of Health Malaysia

  • P’ng Xiu Wen

    Pharmacy Department, Hospital Tengku Ampuan Rahimah, Selangor State Health Department, Ministry of Health Malaysia

  • Tan Huay Synn

    Pharmacy Department, Hospital Tengku Ampuan Rahimah, Selangor State Health Department, Ministry of Health Malaysia

  • Muna Atirah Ramli

    Obstetrics and Gynaecology Department, Hospital Tengku Ampuan Rahimah, Selangor State Health Department, Ministry of Health Malaysia

  • Navamani Nedincheliyin

    Nursing Unit, Obstetrics and Gynaecology Ward, Hospital Tengku Ampuan Rahimah, Selangor State Health Department, Ministry of Health Malaysia

References

1. Litton E, Xiao J, Ho KM. Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. BMJ [Internet]. 2013 Aug 15 [cited 2024 Mar 7];347:f4822. Available from: https://www.bmj.com/content/347/bmj.f4822

2. MedStar Health. IV Iron Dextran Infusion Protocol [Internet]. [cited 2024 Mar 7]. Available from: https://www.medstarhealth.org/news-and-publications/articles-and-research-reports/iv-iron-dextran-infusion-protocol

3. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention. JAMA [Internet]. 1995 Jul 5 [cited 2024 Mar 6];274(1):29–34. Available from: https://jamanetwork.com/journals/jama/fullarticle/389136

4. European Medicines Agency (EMA). New recommendations to manage risk of allergic reactions with intravenous iron-containing medicines [Internet]. [cited 2025 Jan 23]. Available from: https://www.ema.europa.eu/en/news/new-recommendations-manage-risk-allergic-reactions-intravenous-iron-containing-medicines

5. Failla S, Nicolas S, Parmar M. Iron Dextran. Reactions Weekly [Internet]. 2024 Feb 15 [cited 2025 Jan 23];(1378):22. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557747/

6. Failla S, Parmar M. Iron Dextran. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 May 22 [cited 2024 Mar 5]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557747/

7. Electronic Medicines Compendium (emc). CosmoFer - Summary of Product Characteristics (SmPC) [Internet]. [cited 2024 Mar 6]. Available from: https://www.medicines.org.uk/emc/product/48/smpc#gref

8. Api O, Breyman C, Çetiner M, Demir C, Ecder T. Diagnosis and treatment of iron deficiency anemia during pregnancy and the postpartum period: Iron deficiency anemia working group consensus report. Turk J Obstet Gynecol [Internet]. 2015 [cited 2025 Jan 23];12(3):173–181. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC5558393/

9. Myers B, Myers O, Moore J. Comparative efficacy and safety of intravenous ferric carboxymaltose (Ferinject) and iron(III) hydroxide dextran (Cosmofer) in pregnancy [Internet]. [cited 2024 Mar 5]. Available from: http://whqlibdoc.who.int/publications/2008/9789241596657_eng.pdf

10. MIMS Malaysia. Iron Dextran: Uses, Dosage, Side Effects and More [Internet]. [cited 2025 Jan 23]. Available from: https://www.mims.com/malaysia/drug/info/iron-dextran?mtype=generic

11. Rampton D, Folkersen J, Fishbane S, Hedenus M, Howaldt S, Locatelli F, et al. Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management. Haematologica [Internet]. 2014 Nov 1 [cited 2025 Jun 20];99(11):1671–1676. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4222472/

12. Burns DL, Pomposelli JJ. Toxicity of parenteral iron dextran therapy. Kidney Int. 1999 Mar 1;55(69):S119–24.

13. Samsudin S, Dulasi M, Sany S, Balanathan K, Chong SE, Ali A. Safety and Efficacy of Intravenous Iron Sucrose versus Low Molecular Weight Iron Dextran for Treatment of Iron Deficiency Anemia in Pregnancy: A Randomized Controlled Trial. Int J Womens Health [Internet]. 2020 Dec 1 [cited 2025 Sep 12];12:1259–70.

14. Tan SY, Mohd Said M, Abdul Rahman R, Akmar Taha NB. An Investigation of Errors: The Preparation And Administration Of Parenteral Medications In An Intensive Care Unit Of A Tertiary Teaching Hospital In Malaysia. Int J Pharm Pharm Sci [Internet]. 2016 Mar 1 [cited 2025 Jan 23];8(3):325–9. Available from: https://journals.innovareacademics.in/index.php/ijpps/article/view/10098/4863

15. Yatim MF, Othman NH. A Retrospective Analysis of Medication Errors at a Tertiary Hospital in a Northern State of Malaysia. Malaysian Journal of Pharmaceutical Sciences. 2022 Jul 1;20(2):79–92.

16. Dean B, Barber N, Schachter M. What is a prescribing error? Qual Health Care [Internet]. 2000 [cited 2024 Mar 6];9(4):232–7. Available from: https://pubmed.ncbi.nlm.nih.gov/11101708/

17. Ministry of Health Malaysia. e-Incident Report – Patient Safety [Internet]. [cited 2025 Apr 30]. Available from: https://patientsafety.moh.gov.my/v2/?page_id=193

18. Dean B, Schachter M, Vincent C, Barber N. Causes of prescribing errors in hospital inpatients: a prospective study. Lancet [Internet]. 2002 Apr 20 [cited 2025 Aug 31];359(9315):1373–8. Available from: https://pubmed.ncbi.nlm.nih.gov/11978334/

19. Mamula P, Piccoli DA, Peck SN, Markowitz JE, Baldassano RN. Total dose intravenous infusion of iron dextran for iron-deficiency anemia in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr [Internet]. 2002 [cited 2024 Mar 6];34(3):286–90. Available from: https://pubmed.ncbi.nlm.nih.gov/11964953/

20. Ammenwerth E, Schnell-Inderst P, Machan C. The Effect of Electronic Prescribing on Medication Errors and Adverse Drug Events: A Systematic Review. J Am Med Inform Assoc [Internet]. 2008 [cited 2024 Mar 6];15(5):585–600. Available from: https://academic.oup.com/jamia/article/15/5/585/732256

21. Liou JH, Wang SC, Hou YC, Yen CH, Chen HM, Liou WS, et al. Effect of an automated dispensing cabinet system on drug distribution effectiveness in a surgical unit. Heliyon [Internet]. 2023 Nov 1 [cited 2025 Jan 23];9(11):e21443. Available from: https://www.americandatanetwork.com/patient-safety/essential-strategies-for-preventing-medication-errors/

22. Ab Rahman N, Low EV, Kamaruddin F, et al. A retrospective study on prevalence, characteristics, and outcomes of transcribing error: analysis of data from the National Medication Error Reporting System in Malaysia. J Pharm Policy Pract [Internet]. 2025 [cited 2025 Sep 12];18(1):2528244. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC12265094/

23. Kalra P, Bhandari S, Spyridon M, Davinson R, McCafferty K, Mikhail A, et al. SaO001: The Nimo UK Study: Is 1000 Mg Of Intravenous Iron Enough To Achieve Hb Targets In Pre-Dialysis Anaemic Patients? Nephrol Dial Transplant [Internet]. 2018 May 1 [cited 2025 Sep 12];33(suppl_1):i315. Available from: https://dx.doi.org/10.1093/ndt/gfy104.SaO001

Downloads

Published

31-10-2025

Issue

Section

Articles

How to Cite

1.
REDUCING THE PERCENTAGE OF PRESCRIBING ERROR FOR IRON DEXTRAN PRESCRIPTION IN OBSTETRICS AND GYNAECOLOGY (O&G) DEPARTMENT, HOSPITAL TENGKU AMPUAN RAHIMAH (HTAR), KLANG. Q Bulletin [Internet]. 2025 Oct. 31 [cited 2026 Nov. 23];1(34). Available from: https://journal.nih.gov.my/index.php/qbulletin/article/view/313

Similar Articles

11-20 of 40

You may also start an advanced similarity search for this article.